The late postoperative results of isolated mitral valve replacement in 100 patients operated upon from 1961 to 1965 are summarized. Eighty-three of the patients survived operation, and 52 are still alive. Seventy-six percent of patients surviving operation were alive 5 years later, and 64% after 8 years. Of the entire group of 100 patients operated upon, 63% were alive after 5 years and 51% after 8 years. Sixteen of the 31 late deaths were definitely attributable to the presence of the prosthesis: systemic arterial emboli (eight patients), valve thrombosis (two), perivalvular leak (one), ball variance (two), endocarditis (two), and intracerebral hemorrhage due to anticoagulants (one). Congestive heart failure was the primary cause of death in the remaining patients. Predominance of either stenosis or regurgitation preoperatively did not significantly alter late survival, nor did coexistent tricuspid regurgitation. High operative and early postoperative mortality was seen in patients with associated aortic regurgitation. Patients who were in class IV preoperatively had a higher mortality (50% alive at 5 years) than those in class III (70% alive), but no difference in mortality was noted between patients who preoperatively had normal sinus rhythm and those who had atrial fibrillation. Forty-nine percent of patients have sustained systemic emboli, and these have occurred throughout the postoperative period. IT HAS NOW BEEN more than 10 years since the Starr-Edwards prosthesis was first utilized for successful replacement of the diseased mitral valve.' The prosthesis was first employed at the National Heart and Lung Institute in November 1961, and isolated mitral valve replacement was carried out in 100 patients between that date and August 1965. The detailed preoperative clinical and hemodynamic assessments of these 100 patients, the early results of operation, and the findings at postoperative left and right heart catheterization were previously reported.2 Clinical assessments have been continued in all of the 83 patients who survived operation, and pertinent data concerning their courses over postoperative intervals of 7 to 11 years are summarized in the report which follows.
Patients Originally Operated Upon
The 100 patients, at operation, ranged in age from 10 to 64 years (mean 38 years); 53 were female and 47 were male. The operative appearance of the mitral valve indicated rheumatic valvulitis in 98 patients, while the other two had ruptured chordae tendineae secondary to infectious endocarditis. Fifty patients had pure or predominant mitral stenosis, and 50 had pure or predominant mitral regurgitation. Two patients were in functional class II (NYHA), 64 in class III, and 34 in class IV. On physical examination, 36 patients had murmurs of associated tricuspid regurgitation, 24 patients had murmurs of aortic regurgitation, and six patients had murmurs of aortic stenosis. The cardiac rhythm was atrial fibrillation in 77 patients, normal sinus rhythm in 21, and atrial fibrillation with complete heart block in the remaining two. Cardiac catheterization was performed in all patients, and these data and the more detailed preoperative findings have been previously described. 2 Starr-Edwards series 6000 valves were inserted in all patients. A 2M prosthesis was implanted in nine patients, a 3M prosthesis in 59 patients, a 4M valve in 31 patients, and size SM in the remaining patient.
Seventeen of the 100 patients died during the hospital admission at which operation was performed; necropsy was performed in all. Two patients died REPLACEMENT OF MITRAL VALVE Thirteen patients died of progressive congestive 101 heart failure, and necropsy was performed in seven of them. Anatomic causes for failure were apparent go -s>_= in five of the seven: paravalvular leak (one patient, MR 50 Patients after 9 months), thrombosis of valve (two patients, >0 -~~_^s_ was confirmed. Of the six patients who died of YEARS cardiac failure without autopsy, one had uncon- Figure 1 trollable supraventricular tachycardia resulting in rvival after isolated mitral valve replacement: total repulmonary edema, shock, and death, two had sig-'ts and by predominant mitral stenosis (MS) or regurginificant tricuspid regurgitation preoperatively, and ion (MR).
two had significant aortic insufficiency before operation. raoperatively, and the remaining 15 patients died Eight patients died postoperatively of systemic 27 days after operation. Necropsies were obtained in 20 of the 31 patients. Of the 100 patients operated upon, 70% of those who had mitral regurgitation were alive after 5 years, while 56% of those who had mitral stenosis were alive after this interval. Among the 83 survivors of the operation, 81% of those The average age of all 100 patients was 38 years, and of those who died immediately postoperatively, 41 years. Of the 62 patients alive at 5 years, the average age was 36.7 years, and of the 21 patients who survived operation, but lived less than 5 years, the average age was 40.1 years. None of these differences is significant. Operative mortality for patients in class III preoperatively was 13%, and for patients who were class IV the mortality was 26%. At the end of 5 years only 50% of the class IV patients were alive, compared with 70% of the class III patients ( fig.   4 ).
Rhythm
There was no difference in operative or late mortality between those patients in normal sinus Fifty-three percent of the patients who had predominant mitral regurgitation have had postoperative emboli, compared to 43% of patients who had predominant mitral stenosis; the patients who had mitral regurgitation have been at risk 274 patient years (56%) in comparison to 216 patient years (44%) for those who had predominant mitral stenosis. Seven of the 10 patients, however, who either died or have had significant residual disability from emboli are in the mitral regurgitation group. The relationship between valve size and the incidence of emboli was evaluated, since patients in the mitral regurgitation group usually had larger prostheses inserted; there was no correlation. Forty-seven percent of those with 2M Circulation, Volume XLVII, March 1973 protheses, 53% of those with 3M prostheses, and 32% of those with 4M prostheses have had emboli. There was also no correlation between the incidence of emboli and the cardiac rhythm after operation: 47% of patients in atrial fibrillation and 50% of those in normal sinus rhythm sustained emboli.
Systemic arterial emboli have occurred throughout the postoperative period ( fig. 7) . Thirty-three of the 83 operative survivors (40%) had emboli in the first 5 years, and 12 of the 62 patients ( 19%) at risk greater than 5 years have had at least one embolic episode later than 5 years after operation; in seven of these 12 patients this was their first embolic episode ( fig. 8) . Seven of the eight deaths caused by emboli have occurred four or more years postoperatively.
Complications Related to Anticoagulation
Several patients have had significant complications related to warfarin administration. As previously noted, one patient died of a massive intracerebral hemorrhage caused by severe hypoprothrombinemia. Nine other patients have had major episodes of bleeding; gastrointestinal bleeding requiring transfusion occurred in six patients, severe menometrorrhagia in one patient, a diffuse bleeding diathesis in one patient, and a subdural hematoma requiring evacuation followed a minor head injury in the last. months all patients have either been examined at the Clinical Center or current information concerning their status has been obtained from the patient and the referring physician. Twenty-six patients (50%) are asymptomatic (class I), 22 patients (42%) are in functional class II, and four patients (8%) are in class III. Of the 29 living patients who originally had mitral regurgitation, 13 are class I (45%), 13 are class II (45%), and three are class III (10%). Of the 23 patients who had mitral stenosis, 13 are class I (57%), nine are class II (39%), and one is class III (4%). The symptoms of one patient in class III are primarily caused by chronic obstructive lung disease, two others experience mild-to-moderate dyspnea on exertion with no clinical findings of congestive heart failure, and a fourth has significant heart failure with severe tricuspid regurgitation.
Fifteen of the patients who had significant tricuspid regurgitation preoperatively are living: five are class I, nine are class II, and one, previously mentioned, is class III. Seven patients with associated aortic regurgitation pre-and postoperatively are alive: four are class I, and three are class II. ,, ) . Of the 83 patients who survived operation, 18 were in normal sinus rhythm at the time of operation, and 16 of them maintained normal sinus rhythm after operation; two had atrial fibrillation in the early postoperative period, but normal sinus rhythm was restored by external countershock prior to discharge. Of these 18 patients, 13 are alive, and 11 remain in normal sinus rhythm. Sixty-three patients who survived operation were in atrial fibrillation preoperatively: 39 of these patients are living, 13 are in normal sinus rhythm, 25 in atrial fibrillation, and one has a nodal rhythm.
Of the 63 patients who were in atrial fibrillation before operation, seven spontaneously reverted to normal sinus rhythm postoperatively. Three patients were converted with quinidine, and 30 patients by DC countershock. (In 10 additional patients cardioversion was unsuccessful.) Eleven of the 40 patients in whom normal sinus rhythm was reestablished after operation have died: five remained in normal sinus rhythm until death, and six had converted back to atrial fibrillation. Twentynine patients are still living: 13 remain in normal sinus rhythm (44%). Five of the six spontaneous conversions (83%), but only seven of the 22 electrical cardioversions (32%), have remained in a sinus rhythm. Most failures to maintain normal sinus rhythm after electrical cardioversion occurred early. Seventeen patients maintained normal sinus rhythm only temporarily, and of the 13 patients remaining in normal sinus rhythm up to 2 years after operation, 10 are currently alive and only three have reverted to atrial fibrillation.
Though there was no significant difference in operative or late mortality between patients in normal sinus rhythm and those in atrial fibrillation, there is a slight difference in current functional class. Of the 24 patients currently in normal sinus rhythm, 16 are class I (67%), while among 28 patients in atrial fibrillation only 11 (40% ) are asymptomatic.
Discussion
The Starr-Edwards mitral prosthesis has been employed more extensively and for a longer period than any other valve substitute, and the long-term assessments of the morbidity and mortality associated with its use provide the physician with a realistic prognosis for the patient in whom mitral valve replacement is required. Operative mortality was 17% in this early group of patients, but in this clinic and others the operative risk has steadily diminished as greater experience has been gained with the operative methods and postoperative management of these patients. Five years after operation, 76% of the patients who survived operation are alive, and 64% are alive after 8 years; similar survival data have been reported by others. Starr6 has described a 79% 5-year survival of 89 patients living 1 month after operation, Duvoisin7 5-year survival of 70%, and Kerth8 79% 5-year survival.
Late mortality can be divided into deaths related to the prosthesis and those related to the patient's disease. In the present group of patients, 16 (52%) of the 31 late deaths were definitely attributable to the presence of the prosthesis: eight deaths from emboli, two from endocarditis, two from ball variance, two from prosthetic thrombosis, one from a paravalvular leak, and one from hemorrhage secondary to anticoagulation. The prosthesis may have been responsible for death in additional patients in whom necropsy was not performed. Starr6 has reported 16 of 37 late deaths to be prosthesis related, and Duvoisin7 19 of 35 late deaths; other centers have noted a similar proportion.9 ' 10 The cloth-covered prosthesis has lowered the risk of prosthetic thrombosis and systemic embolism," and the metal poppet utilized in the current (model 6320) prosthesis presumably negates the possibility of ball variance. The use of appropriate antibiotic prophylaxis during secondary operative procedures has essentially eliminated the risk of bacterial endocarditis.12 Thus, since the major causes of prosthesis-related death have now been markedly reduced, or eliminated, it is reasonable to consider survival of the present patients when these causes are subtracted: 84% survival at 5 years, and 79% of patients alive 8 years after operation.
Congestive heart failure was the most common cause of nonprosthesis-related late mortality in this series and others.6' 9 The majority of these deaths occurred in the early postoperative years in patients in whom little or no improvement of failure occurred after operation. Several of the deaths due to congestive failure occurred in patients with residual aortic or tricuspid regurgitation. It is likely that most of these patients would have a tricuspid annuloplasty or tricuspid replacement, or aortic valve replacement if operated upon at the present time, since the attitude toward these associated valve lesions has become more aggressive. Hopefully such an attitude will prove to reduce the incidence of late deaths from failure.
Circulation, Volume XLVII, March 1973 Evaluation of preoperative and early postoperative clinical and hemodyniamic factors, in an attempt to determine which patients were at high risk for operative or late death, revealed only that class IV patients had a statistically significant higher combined operative and late mortality (P < 0.05). Although patients with associated aortic regurgitation and those with elevated left venitricular enid-diastolic pressure had a higher operative mortality, those with low cardiac index and residual pulmonary hypertension had a higher late mortality, and those with severe pulmonary hypertension had an increased combined mortality, these factors were not significant to P < 0.05. Litwak et al. 13 evaluated 110 patients after isolated mitral valve replacement and reported increased operative mortality in patients with atrial fibrillation, associated aortic regurgitation, low cardiac index, and high pulmonary artery pressure. In his data only low cardiac index was significant at the P< 0.05 level, and our data show no correlation between decreased cardiac index and operative risk. Najafi et al.9 correlated pulmonary hypertension and preoperative functional classification with operative and late risk, but no statistical analysis was presented. A study of risk factors in a larger group of patients is necessary to attach statistical significance to these clinical impressions expressed by the several groups. Preliminary data from the Cooperative Study on Results of Cardiac Surgery14 indicate a significant (P < 0.01) increase in mortality in patients with pulmonary hypertension, but a full risk-factor analysis is not yet available.
Thromboembolism has been the major cause of death and disability in the late postoperative period. The percentage of patients who sustained emboli was similar to Starr's experience15 (49 vs 57%). A significant number of our patients, however, have had major or even fatal emboli more than 5 years after operation, and the risk of a patient having a first embolus was considerable until 6 years after operation. This experience is in contrast to that of Duvoisin7 who noted a negligible incidence of first thromboembolism after the third postoperative year, and to that of Starr15 who has not noted any patient to have a first embolus more than 6 years after operation. The lack of correlation of rhythm with emboli after valve replacement is in agreement with Herr, et al. 16 but contradicts several reports17' 18 of an increased incidence of emboli in patients in atrial fibrillation.
Over 45% of our patients have remained in normal sinus rhythm after the early postoperative period.
Circulation, Volume XLVII, March 1973 Those in normal sinus rhythm preoperatively have remained in sinus rhythm, as have those who spontaneously converted to a sinus mechanism postoperatively. Despite a high initial conversion rate in those patients electrically cardioverted, few of these patients maintain sinus rhythm.
Finally, important consideration must be given to the gratifying long-term symptomatic improvement in the large majority of patients. Over 90% of surviving patients are currently in functional class I or II, 6/-10 years after operation, and most have resumed useful and productive lives. With the considerable progress in operative technic, postoperative care, and prosthesis design that has taken place over the last decade, prosthetic replacement of the mitral valve can now offer even more significant long-term improvement at a distinctly reduced risk.
